Quarterly Results: Eli Lilly’s Zepbound Sales on Fast-Track to Become Biggest Drug of All Time
Indianapolis, IN – Eli Lilly’s quarterly results have just been released, marking the first time that the company’s sales of Zepbound have been included in the report. Analysts are predicting that Zepbound could generate over a billion dollars in sales in its first year on the market, potentially becoming the biggest drug of all time. The fourth-quarter results for Eli Lilly have exceeded Wall Street’s expectations. Earnings per share came in at $2.49 adjusted, compared …